Literature DB >> 18003961

The anatomy of medical school patenting.

Pierre Azoulay1, Ryan Michigan, Bhaven N Sampat.   

Abstract

BACKGROUND: Although issues related to patenting by faculty at academic medical centers have been the source of much controversy, there is little systematic evidence of the growth of these activities, their distribution among academic departments, and their relationship to faculty research efforts.
METHODS: We pooled data on medical school faculty, National Institutes of Health (NIH) grant activity, and patenting to examine changes in the propensity to apply for a patent during the period from 1981 through 2000 that was subsequently granted, the distribution of these activities among departments, and the relationships between patenting and variables associated with individual faculty members. These variables included sex, academic degree, years since the last academic degree was earned, patenting by departmental peers, and NIH funding history. In addition to basic descriptive statistics, we estimated Poisson regression models based on the number of patents a faculty member applied for as a function of these variables.
RESULTS: Applications for patents that were subsequently granted per medical school faculty increased dramatically during the period from 1981 through 2000. Although most patenting activity was carried out by faculty members in clinical departments, their rate of patents was low relative to that of faculty members in basic science departments. Regression results showed that persons were more likely to patent if they had recent NIH funding, were male, had Ph.D. degrees, were more experienced faculty members, and worked in departments with higher patenting rates.
CONCLUSIONS: Although the number of patents granted to medical school faculty increased dramatically during this period, patent activity was concentrated among a small number of departments and faculty members. Moreover, persons who had recently received NIH funding were more likely to apply for a patent than those who had not received such funding. Copyright 2007 Massachusetts Medical Society.

Entities:  

Mesh:

Year:  2007        PMID: 18003961     DOI: 10.1056/NEJMsa067417

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  10 in total

1.  Academic patents and access to medicines in developing countries.

Authors:  Bhaven N Sampat
Journal:  Am J Public Health       Date:  2008-11-13       Impact factor: 9.308

2.  Mobility, retention and productivity of genomics scientists in the United States.

Authors:  Kenneth Guang-Lih Huang; Gokhan Ertug
Journal:  Nat Biotechnol       Date:  2014-09       Impact factor: 54.908

3.  Corporate Funding for Schools of Public Health: Confronting the Ethical and Economic Challenges.

Authors:  Ronald Bayer; Bhaven N Sampat
Journal:  Am J Public Health       Date:  2016-02-18       Impact factor: 9.308

4.  Public R&D Investments and Private-sector Patenting: Evidence from NIH Funding Rules.

Authors:  Pierre Azoulay; Danielle Li; Joshua S Graff Zivin; Bhaven N Sampat
Journal:  Rev Econ Stud       Date:  2018-06-15

5.  Citations in Life Science Patents to Publicly Funded Research at Academic Medical Centers.

Authors:  Bhaven N Sampat; Harold Alan Pincus
Journal:  Clin Transl Sci       Date:  2015-12       Impact factor: 4.689

6.  Opportunities and benefits as determinants of the direction of scientific research.

Authors:  Jay Bhattacharya; Mikko Packalen
Journal:  J Health Econ       Date:  2011-05-25       Impact factor: 3.883

7.  Financing of U.S. biomedical research and new drug approvals across therapeutic areas.

Authors:  E Ray Dorsey; Joel P Thompson; Melisa Carrasco; Jason de Roulet; Philip Vitticore; Sean Nicholson; S Claiborne Johnston; Robert G Holloway; Hamilton Moses
Journal:  PLoS One       Date:  2009-09-11       Impact factor: 3.240

8.  Patenting of university and non-university public research organisations in Germany: evidence from patent applications for medical research results.

Authors:  Peter Tinnemann; Jonas Ozbay; Victoria A Saint; Stefan N Willich
Journal:  PLoS One       Date:  2010-11-18       Impact factor: 3.240

9.  Accountability in patenting of federally funded research.

Authors:  Arti K Rai; Bhaven N Sampat
Journal:  Nat Biotechnol       Date:  2012-10       Impact factor: 54.908

10.  Clinicians' contributions to the development of coronary artery stents: a qualitative study of transformative device innovation.

Authors:  Aaron S Kesselheim; Shuai Xu; Jerry Avorn
Journal:  PLoS One       Date:  2014-02-12       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.